ATM and cancer: Moreover, ATR inactivation has been proposed to be synthetic lethal with ATM inactivation because of the overlapping substrates and functions of ATR and ATM, and because ATM appears inactivated in a significant proportion of cancers (10–16% of colorectal, gastric, lung and prostate cancers) [92].